Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma

Dai Chihara; Jason R. Westin; Roberto N. Miranda; Chan Y. Cheah; Yasuhiro Oki; Francesco Turturro; Jorge E. Romaguera; Sattva S. Neelapu; Lorreta J. Nastoupil; Luis E. Fayad; M. Alma Rodriguez; Nathan H. Fowler; Robert Z. Orlowski; Michael Wang; Fredrick B. Hagemeister; L. Jeffrey Medeiros; Michelle A. Fanale

doi:10.1111/bjh.14226

Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma

Dai Chihara, Jason R. Westin, Roberto N. Miranda, Chan Y. Cheah, Yasuhiro Oki, Francesco Turturro, Jorge E. Romaguera, Sattva S. Neelapu, Lorreta J. Nastoupil, Luis E. Fayad, M. Alma Rodriguez, Nathan H. Fowler, Robert Z. Orlowski, Michael Wang, Fredrick B. Hagemeister, L. Jeffrey Medeiros, Michelle A. Fanale

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	503-506
Number of pages	4
Journal	British Journal of Haematology
Volume	179
Issue number	3
DOIs	https://doi.org/10.1111/bjh.14226
State	Published - Nov 2017

Keywords

ABVD
EPOCH
gray-zone lymphoma
treatment

ASJC Scopus subject areas

Hematology

Access to Document

10.1111/bjh.14226

Cite this

Chihara, D., Westin, J. R., Miranda, R. N., Cheah, C. Y., Oki, Y., Turturro, F., Romaguera, J. E., Neelapu, S. S., Nastoupil, L. J., Fayad, L. E., Rodriguez, M. A., Fowler, N. H., Orlowski, R. Z., Wang, M., Hagemeister, F. B., Medeiros, L. J., & Fanale, M. A. (2017). Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma. British Journal of Haematology, 179(3), 503-506. https://doi.org/10.1111/bjh.14226

Chihara, D , Westin, JR , Miranda, RN, Cheah, CY, Oki, Y, Turturro, F, Romaguera, JE, Neelapu, SS , Nastoupil, LJ , Fayad, LE, Rodriguez, MA, Fowler, NH, Orlowski, RZ , Wang, M, Hagemeister, FB, Medeiros, LJ & Fanale, MA 2017, 'Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma', British Journal of Haematology, vol. 179, no. 3, pp. 503-506. https://doi.org/10.1111/bjh.14226

@article{b7b28a44d292426592d51918c0469a2a,

title = "Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma",

keywords = "ABVD, EPOCH, gray-zone lymphoma, treatment",

author = "Dai Chihara and Westin, {Jason R.} and Miranda, {Roberto N.} and Cheah, {Chan Y.} and Yasuhiro Oki and Francesco Turturro and Romaguera, {Jorge E.} and Neelapu, {Sattva S.} and Nastoupil, {Lorreta J.} and Fayad, {Luis E.} and Rodriguez, {M. Alma} and Fowler, {Nathan H.} and Orlowski, {Robert Z.} and Michael Wang and Hagemeister, {Fredrick B.} and Medeiros, {L. Jeffrey} and Fanale, {Michelle A.}",

year = "2017",

month = nov,

doi = "10.1111/bjh.14226",

language = "English (US)",

volume = "179",

pages = "503--506",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma

AU - Chihara, Dai

AU - Westin, Jason R.

AU - Miranda, Roberto N.

AU - Cheah, Chan Y.

AU - Oki, Yasuhiro

AU - Turturro, Francesco

AU - Romaguera, Jorge E.

AU - Neelapu, Sattva S.

AU - Nastoupil, Lorreta J.

AU - Fayad, Luis E.

AU - Rodriguez, M. Alma

AU - Fowler, Nathan H.

AU - Orlowski, Robert Z.

AU - Wang, Michael

AU - Hagemeister, Fredrick B.

AU - Medeiros, L. Jeffrey

AU - Fanale, Michelle A.

PY - 2017/11

Y1 - 2017/11

KW - ABVD

KW - EPOCH

KW - gray-zone lymphoma

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=84994160273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994160273&partnerID=8YFLogxK

U2 - 10.1111/bjh.14226

DO - 10.1111/bjh.14226

M3 - Letter

C2 - 27378601

AN - SCOPUS:84994160273

SN - 0007-1048

VL - 179

SP - 503

EP - 506

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 3

ER -

Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this